Glaxosmithkline Plc Adr Stock Price History

GSK Stock  USD 39.24  0.17  0.43%   
Below is the normalized historical share price chart for GlaxoSmithKline PLC ADR extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlaxoSmithKline PLC stands at 39.24, as last reported on the 23rd of March, with the highest price reaching 39.50 and the lowest price hitting 39.15 during the day.
IPO Date
9th of July 1986
200 Day MA
38.0911
50 Day MA
36.5928
Beta
0.286
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in GlaxoSmithKline Stock, it is important to understand the factors that can impact its price. GlaxoSmithKline PLC appears to be very steady, given 3 months investment horizon. GlaxoSmithKline PLC ADR holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for GlaxoSmithKline PLC ADR, which you can use to evaluate the volatility of the firm. Please utilize GlaxoSmithKline PLC's risk adjusted performance of 0.1356, and Market Risk Adjusted Performance of 0.7942 to validate if our risk estimates are consistent with your expectations.
  
At this time, GlaxoSmithKline PLC's Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.6 B this year, although the value of Other Stockholder Equity will most likely fall to about 2.9 B. . Price Earnings Ratio is expected to rise to 27.57 this year, although the value of Price To Sales Ratio will most likely fall to 1.66. GlaxoSmithKline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1541

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGSK
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.72
  actual daily
15
85% of assets are more volatile

Expected Return

 0.26
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.15
  actual daily
12
88% of assets perform better
Based on monthly moving average GlaxoSmithKline PLC is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding it to a well-diversified portfolio.
Price Book
4.4892
Enterprise Value Ebitda
11.2108
Price Sales
2.5451
Shares Float
3.9 B
Dividend Share
0.61

GlaxoSmithKline PLC Stock Price History Chart

There are several ways to analyze GlaxoSmithKline Stock price data. The simplest method is using a basic GlaxoSmithKline candlestick price chart, which shows GlaxoSmithKline PLC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 18, 202540.39
Lowest PriceJanuary 14, 202531.73

GlaxoSmithKline PLC March 23, 2025 Stock Price Synopsis

Various analyses of GlaxoSmithKline PLC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell GlaxoSmithKline Stock. It can be used to describe the percentage change in the price of GlaxoSmithKline PLC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of GlaxoSmithKline Stock.
GlaxoSmithKline PLC Price Action Indicator(0.17)
GlaxoSmithKline PLC Price Daily Balance Of Power(0.49)
GlaxoSmithKline PLC Price Rate Of Daily Change 1.00 

GlaxoSmithKline PLC March 23, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in GlaxoSmithKline Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use GlaxoSmithKline PLC intraday prices and daily technical indicators to check the level of noise trading in GlaxoSmithKline Stock and then apply it to test your longer-term investment strategies against GlaxoSmithKline.

GlaxoSmithKline Stock Price History Data

The price series of GlaxoSmithKline PLC for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 8.66 with a coefficient of variation of 6.99. Under current investment horizon, the daily prices are spread out with arithmetic mean of 35.67. The median price for the last 90 days is 35.11. The company completed 1226:1000 stock split on 30th of September 2022. GlaxoSmithKline PLC ADR completed dividends distribution on 2025-02-21.
OpenHighLowCloseVolume
03/23/2025
 39.29  39.50  39.15  39.24 
03/21/2025 39.29  39.50  39.15  39.24  4,020,556 
03/20/2025 39.58  39.66  39.24  39.41  3,346,100 
03/19/2025 39.55  39.80  39.27  39.55  4,421,024 
03/18/2025 40.23  40.39  40.12  40.39  3,655,702 
03/17/2025 39.88  40.47  39.85  40.25  3,970,339 
03/14/2025 39.21  39.61  39.05  39.49  4,939,458 
03/13/2025 39.02  39.39  38.92  39.23  3,718,725 
03/12/2025 39.32  39.32  38.78  38.88  5,600,973 
03/11/2025 40.12  40.12  39.36  39.50  5,763,381 
03/10/2025 40.37  40.80  40.10  40.32  7,267,182 
03/07/2025 39.50  40.59  39.48  40.05  8,121,906 
03/06/2025 38.61  39.42  38.60  39.30  5,511,200 
03/05/2025 38.40  38.86  38.37  38.81  2,464,952 
03/04/2025 38.66  39.19  38.36  38.43  6,829,569 
03/03/2025 38.17  38.41  37.78  37.95  3,722,470 
02/28/2025 37.64  37.69  37.15  37.59  6,046,000 
02/27/2025 37.07  37.38  36.99  37.30  7,168,264 
02/26/2025 37.81  37.83  37.35  37.40  7,938,470 
02/25/2025 37.56  38.40  37.56  38.36  10,534,971 
02/24/2025 36.82  37.14  36.72  37.08  2,857,899 
02/21/2025 36.20  36.67  36.05  36.64  5,644,704 
02/20/2025 36.32  36.82  36.22  36.56  6,244,672 
02/19/2025 36.10  36.25  35.96  36.14  3,408,594 
02/18/2025 36.19  36.45  36.07  36.21  4,368,601 
02/14/2025 36.08  36.21  35.77  35.78  4,541,919 
02/13/2025 35.78  36.22  35.61  36.15  4,462,616 
02/12/2025 35.33  35.87  35.14  35.74  3,619,986 
02/11/2025 35.92  35.96  35.59  35.68  4,893,117 
02/10/2025 35.98  36.50  35.97  36.07  4,539,615 
02/07/2025 36.09  36.12  35.58  35.65  5,356,543 
02/06/2025 37.11  37.20  35.98  35.99  7,167,978 
02/05/2025 36.66  37.50  36.63  37.29  10,193,210 
02/04/2025 34.22  34.60  33.85  34.46  7,120,968 
02/03/2025 34.49  34.82  34.21  34.52  3,279,980 
01/31/2025 34.81  35.13  34.68  34.89  5,112,730 
01/30/2025 34.69  35.20  34.54  34.98  5,020,445 
01/29/2025 34.57  34.87  34.56  34.68  6,057,362 
01/28/2025 35.13  35.20  34.45  34.72  4,552,898 
01/27/2025 34.45  35.11  34.45  35.11  6,505,288 
01/24/2025 33.64  33.94  33.58  33.90  3,165,928 
01/23/2025 33.48  33.79  33.42  33.68  3,738,614 
01/22/2025 33.28  33.36  33.05  33.07  3,546,186 
01/21/2025 33.21  33.42  33.17  33.41  4,111,320 
01/17/2025 33.24  33.24  32.89  33.07  3,930,595 
01/16/2025 32.46  33.15  32.37  33.08  4,535,039 
01/15/2025 32.43  32.56  32.16  32.44  4,782,402 
01/14/2025 31.87  31.93  31.37  31.73  6,251,524 
01/13/2025 32.39  32.50  32.20  32.35  4,673,828 
01/10/2025 32.90  33.03  32.65  32.73  3,842,142 
01/08/2025 33.34  33.55  33.03  33.38  2,709,540 
01/07/2025 33.60  34.09  33.60  33.72  3,031,253 
01/06/2025 33.18  33.75  33.06  33.59  3,333,753 
01/03/2025 33.61  33.61  33.05  33.11  2,903,352 
01/02/2025 33.57  33.82  33.47  33.58  1,999,102 
12/31/2024 33.46  33.65  33.27  33.45  2,413,894 
12/30/2024 33.71  33.71  33.19  33.28  5,081,275 
12/27/2024 33.60  33.80  33.50  33.71  3,174,412 
12/26/2024 33.63  33.78  33.52  33.75  1,993,615 
12/24/2024 33.49  33.84  33.47  33.66  1,383,078 
12/23/2024 33.49  33.74  33.27  33.69  3,228,802 

About GlaxoSmithKline PLC Stock history

GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
Last ReportedProjected for Next Year
Common Stock Shares Outstanding4.1 B2.2 B
Net Income Applicable To Common Shares13.5 B14.1 B

GlaxoSmithKline PLC Stock Technical Analysis

GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GlaxoSmithKline PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module

GlaxoSmithKline PLC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GlaxoSmithKline PLC's price direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.173
Dividend Share
0.61
Earnings Share
1.61
Revenue Per Share
15.392
Quarterly Revenue Growth
0.008
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.